Our partner VPH – now officially rebranded as VPH: The Society for In Silico Medicine – has launched an ambitious new vision to guide the next decade of progress in digital health. As a long-standing collaborator in advancing high-performance simulation and modelling, dealiiX is pleased to share this important milestone with our community.
Over the past decade, VPH has played a foundational role in shaping the field of in silico medicine, from community building and scientific leadership to regulatory engagement and policy advocacy. Their renewed strategy reflects a growing and increasingly interconnected ecosystem and aims to empower research teams with greater visibility, support, and access to a thriving international network.
A significant part of VPH’s evolution is its strengthened role in regulatory science. Years of collaboration with the European Commission, EMA, FDA, notified bodies, and other stakeholders are now translating into concrete initiatives that will influence future governance frameworks for emerging digital health technologies. This progress aligns closely with dealiiX’s mission of advancing trustworthy, HPC-driven modelling tools that can support real-world clinical and industrial applications.
Looking ahead, VPH is placing renewed emphasis on engagement with clinicians and patients. Their vision prioritises responsible innovation, co-creation, and trust-building—values that resonate strongly with the broader in silico community. By promoting education, transparency, and inclusiveness, VPH aims to ensure that digital technologies deliver meaningful, equitable benefits for healthcare systems and society.
As a membership-based organisation, VPH continues to draw strength from its community. A more diverse and representative membership will help sustain scientific excellence, enrich collaboration opportunities, and reinforce the collective voice needed to engage effectively with policymakers, regulators, and industry actors.
To learn more about this new chapter and hear the insights of leading experts shaping the future of in silico medicine, you can watch the full recording of the event “In Silico Medicine and Beyond: A New VPH Chapter”, featuring contributions from:
- Prof. Liesbet Geris
- Dr Eric Vibert
- Tina Morrison
- Steven Bourke
This evolution marks an exciting moment for the entire in silico community, and dealiiX is proud to be part of the journey toward an inclusive, credible, and impactful future for digital healthcare.